Table 1

Patient characteristics and SOX11 staining
Method Entity N (M/F) Age range (mean) SOX11-C1 staining (P/T)1
IHC-P, TMA2 MCL 15 (12/3) 44-82 (68) 15/15, (15/16)5
IHC-P, TMA FL 15 (7/8) 49-92 (66) 0/15
IHC-P, TMA CLL 14 (10/4) 41-82 (70) 0/14
IHC-P, WTS3 HCL 7 (7/0) 37-64 (51) 0/7
IHC-P, WTS BL 4 (2/2) 3-12 (8) 2/4
IHC-P, WTS T-lymphoblastic 4 (3/1) 13-70 (53) 0/4
IHC-P, WTS B-lymphoblastic 2 (0/2) 14-69 (42) 0/2
IHC-P, TMA Tonsil 13 (5/8) 5-48 (24) 0/13
IHC-P, WTS Bone marrow 5 (3/2) 30-74 (49) 0/5
Flow cytometry MCL 54 (2/3) 50-80 (69) 5/5
Flow cytometry FL 2 (0/2) 70-76 0/2
Flow cytometry PBMC n.a n.a 0/2
Flow cytometry Tonsil n.a <7 0/2

1Number of positive (P) cases/Total number (T) of tested cases in IHC or flow cytometry.

2Tissue micro array (TMA).

3Whole tissue section (WTS).

4 Includes two cases of peripheral blood.

5A single previously negative case was selected, tested (WTS) and confirmed to be negative in IHC.

Nordström et al.

Nordström et al. BMC Cancer 2012 12:269   doi:10.1186/1471-2407-12-269

Open Data